Cote d'Ivoire vs Senegal: Cause of death, by non-communicable diseases, ages 5-14, male
Cote d'Ivoire
22.2%
in 2021
Senegal
22.3%
in 2021
Cote d'Ivoire rank
141st
Senegal rank
139th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Cote d'Ivoire
- Senegal
How they compare
Senegal currently reports 22.3% against 22.2% in Cote d'Ivoire, a difference of 0.1%.
Across all 6 years both countries report, Senegal has been ahead every year.
Cote d'Ivoire ranks 141st and Senegal ranks 139th of 185 countries.
Senegal has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cote d'Ivoire | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 12.5% | 15.2% | 2.7% | Senegal |
| 2010s | 18.4% | 21.7% | 3.3% | Senegal |
| 2020s | 21.8% | 22.3% | 0.6% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Cote d'Ivoire or Senegal?
- Senegal, at 22.3% against 22.2% in Cote d'Ivoire as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Cote d'Ivoire and Senegal?
- 0.1%, with Senegal ahead.
- How many years of comparable data are there for Cote d'Ivoire and Senegal?
- 6 years are reported by both, from 2000 to 2021.
- How do Cote d'Ivoire and Senegal rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Cote d'Ivoire ranks 141st and Senegal ranks 139th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.